Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $353.79 | $7.23 | 4,795.89% | 7,075.80x | 340.15x | 7.84x | 9.49x | 18.92x | $529.27M | 1.36% | $4.13B | 37.48 | $37.06B | 116.52 | ||
| CORT | CORCEPT THERAPEUTICS INC | $76.10 | $32.45 | 134.50% | 76.10x | 74.79x | 10.63x | 12.67x | 1.06x | $162.57M | 2.06% | $631.90M | 6.10 | $7.89B | 119.53 | ||
| NVO | NOVO NORDISK A S | $49.00 | $150.35 | -67.41% | 13.63x | 2.05x | 4.48x | 8.32x | 0.14x | $9.34B | 4.29% | $26.18B | 5.89 | $228.38B | 9.21 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $460.76 | $28.81 | 1,499.26% | 1,486.32x | 316.48x | 18.87x | 260.26x | 6.33x | $221.36M | 0.37% | $233.89M | 1.78 | $62.60B | 412.02 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.77 | $4.96 | -64.35% | 25.29x | 13.48x | 2.27x | 2.69x | 0.14x | -$11.69M | -8.31% | $52.91M | 0.67 | $136.88M | 15.43 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.68 | $11.23 | -13.80% | 20.17x | 7.89x | 6.42x | 4.09x | 0.43x | -$23.64M | -4.37% | $133.17M | 2.38 | $553.24M | 8.23 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.16 | $15.02 | 180.65% | 86.04x | 39.84x | 5.27x | 5.97x | 1.28x | $101.73M | 3.23% | $535.38M | 7.17 | $3.03B | 56.56 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $206.05 | $61.12 | 237.10% | 89.20x | 29.43x | 16.06x | 4.27x | 1.60x | $30.76M | 0.76% | $950.17M | 48.53 | $4.37B | 42.39 | ||
| GMAB | GENMAB A | $30.57 | $113.87 | -73.15% | 13.05x | 1.76x | 5.51x | 3.41x | 0.11x | $1.19B | 6.08% | $5.75B | 8.96 | $18.01B | 9.00 | ||
| ARGX | ARGENX SE | $914.59 | $256.34 | 256.79% | 36.55x | 54.65x | 29,502.90x | 7.78x | 3.06x | $467.72M | 0.84% | $7.17B | 117.50 | $53.42B | 65.84 | ||
| VCEL | VERICEL CORP | $38.95 | $7.23 | 438.36% | 149.81x | 173.57x | 7.60x | 6.12x | 2.52x | $20.38M | 1.04% | $321.86M | 6.38 | $1.97B | 67.12 | ||
| RPRX | ROYALTY PHARMA PLC | $38.65 | $41.45 | -6.75% | 21.96x | 8.43x | 7.10x | 2.32x | 0.46x | $2.11B | 12.65% | $9.62B | 22.28 | $30.32B | 29.03 | ||
| KRYS | KRYSTAL BIOTECH INC | $204.10 | $83.55 | 144.27% | 29.58x | 40.07x | 15.84x | 5.20x | 1.74x | $166.02M | 2.81% | $1.14B | 39.30 | $5.54B | 28.64 | ||
| TECH | BIO-TECHNE CORP | $57.81 | $16.17 | 257.59% | 115.62x | 28.29x | 7.39x | 4.58x | 1.62x | $224.06M | 2.49% | $1.97B | 12.65 | $9.26B | 41.91 | ||
| CRMD | CORMEDIX INC | $10.03 | $16.53 | -39.32% | 4.42x | 4.73x | 3.55x | 2.11x | 1.12x | $74.42M | 9.77% | $374.13M | 4.93 | $890.68M | 7.93 | ||
| HALO | HALOZYME THERAPEUTICS INC | $70.25 | $76.48 | -8.15% | 14.37x | 11.19x | 6.63x | 16.39x | 0.54x | $602.40M | 7.32% | $503.92M | 4.30 | $9.35B | 11.06 | ||
| MDXG | MIMEDX GROUP INC | $6.48 | $3.59 | 80.27% | 23.14x | 14.95x | 2.44x | 4.02x | 1.22x | $66.82M | 6.96% | $238.95M | 1.61 | $835.83M | 12.08 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.57 | $0.85 | 791.50% | 108.14x | 71.82x | 6.41x | 7.16x | 6.35x | $3.05M | 0.45% | $101.92M | 1.12 | $690.00M | 52.16 | ||
| VCYT | VERACYTE INC | $39.93 | $8.85 | 351.29% | 102.38x | 99.95x | 6.35x | 2.51x | 2.25x | $98.21M | 3.13% | $1.26B | 15.98 | $2.88B | 50.52 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $52.56 | $41.72 | 25.98% | 19.32x | 17.31x | 3.26x | 1.67x | 0.75x | $832.13M | 8.24% | $6.06B | 31.54 | $9.44B | 12.22 | ||
| INVA | INNOVIVA INC | $21.27 | $18.10 | 17.50% | 11.25x | 17.87x | 3.78x | 1.57x | 1.11x | $196.54M | 13.38% | $1.01B | 14.63 | $1.37B | 6.38 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $421.03 | $172.01 | 144.77% | 29.42x | 22.91x | 9.18x | 6.17x | 1.76x | $3.34B | 3.10% | $17.32B | 67.76 | $103.72B | 22.25 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.20 | $7.10 | 114.11% | 26.21x | 22.99x | 7.54x | 5.48x | 1.51x | $119.87M | 5.98% | $365.77M | 2.78 | $2.01B | 19.41 | ||
| EXEL | EXELIXIS INC | $42.14 | $27.11 | 55.44% | 17.13x | 17.58x | 4.94x | 5.23x | 1.22x | $779.77M | 6.89% | $2.16B | 8.05 | $11.10B | 11.96 | ||
| ADMA | ADMA BIOLOGICS INC | $15.95 | $9.24 | 72.53% | 18.13x | 26.35x | 7.79x | 8.80x | 1.43x | $40.73M | 1.07% | $431.19M | 1.81 | $3.81B | 22.12 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.31 | $39.46 | -15.58% | 10.31x | 10.20x | 2.32x | 2.30x | 0.60x | $296.89M | 15.49% | $835.12M | 14.51 | $1.44B | 5.34 | ||
| INCY | INCYTE CORP | $101.32 | $66.61 | 52.11% | 16.77x | 14.55x | 4.12x | 4.28x | 1.19x | $1.20B | 6.04% | $4.65B | 23.77 | $17.47B | 10.38 | ||
| UTHR | UNITED THERAPEUTICS CORP | $476.54 | $192.94 | 146.99% | 16.73x | 16.97x | 6.67x | 3.11x | 6.47x | $1.12B | 5.37% | $6.59B | 150.46 | $19.18B | 10.82 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.51 | $10.80 | 108.39% | 12.58x | 15.14x | 4.77x | 3.01x | 21.23x | $234.54M | 8.50% | $920.25M | 7.51 | $2.08B | 6.42 | ||
| MNKD | MANNKIND CORP | $5.00 | $1.27 | 293.64% | 50.00x | 52.80x | 4.89x | -34.46x | 2.69x | $43.39M | 2.82% | -$44.55M | -0.15 | $1.77B | 24.15 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $702.75 | $347.94 | 101.97% | 16.17x | 16.44x | 5.11x | 2.39x | 2.74x | $4.22B | 5.80% | $30.96B | 298.82 | $74.06B | 12.96 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.